Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials.
Kannan SridharanGowri SivaramakrishnanPublished in: British journal of clinical pharmacology (2018)
To conclude, rhEGF, rhPDGF and autologous PRP significantly improved the healing rate when used as adjuvants to standard of care, of which rhEGF may perform better than other growth factors. The strength of most of the outcomes assessed was low and the findings may not be applicable for DFU with infection or osteomyelitis. The findings of this study needs to be considered with caution as the results might change with findings from head-to-head studies.